Tuberculosis Drug Market Size, Share and Forecast (2019-2026)
In 2015, about 10.4 million new incidents of TB cases were reported worldwide, of which 6.01 million (50%-55%) were men, 3.6 million (30%-35%) were women, and one million (5%-10%) were children.
(EMAILWIRE.COM, August 30, 2019 ) Market Overview
The Global Tuberculosis Drug market is expected to grow at a CAGR of XX% to reach a market value of USD XX million by 2026.
Tuberculosis (TB), known as poor mans disease, is caused by Mycobacterium tuberculosis germs that are spread from person to person through the air.
TB usually affects the lungs and affects the other parts of the body such as the brain, the kidneys, or the spine. Across the globe, almost two billion people are infected with M. tuberculosis.
Market Dynamics
The primary factors driving the global tuberculosis drug market have increased the incidence of TB in Africa and Asia, Emergence of MDR-TB and XDR-TB strains and Increase in an outbreak of TB-HIV co-infection.
The World Health Organization (WHO) the incidence rates in Asia and Africa are high when compared with America and Europe.
The incidence rates are high due to lack of infrastructure, inadequate healthcare facilities, socioeconomic, untapped markets, and behavioral issues in these areas.
Africa has the highest incidence and prevalence rates of TB compared with any other region in the world, with more than three million new TB cases each year.
Market Segmentation
By Therapy Type
First Line Drugs Therapy
Second Line Drugs Therapy
Combination Drugs Therapy
By Type
Latent TB Type
Active Type
View full report: https://www.datamintelligence.com/research-report/tuberculosis-drug-market
Geographical Share
North America
Europe
South America
Asia Pacific
The Middle East and Africa
Key players
Pfizer Inc.
Lupin Laboratories Ltd
AstraZeneca
Novartis AG
Cipla Ltd
Download free sample: https://www.datamintelligence.com/download-sample/tuberculosis-drug-market
About Us
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
The Global Tuberculosis Drug market is expected to grow at a CAGR of XX% to reach a market value of USD XX million by 2026.
Tuberculosis (TB), known as poor mans disease, is caused by Mycobacterium tuberculosis germs that are spread from person to person through the air.
TB usually affects the lungs and affects the other parts of the body such as the brain, the kidneys, or the spine. Across the globe, almost two billion people are infected with M. tuberculosis.
Market Dynamics
The primary factors driving the global tuberculosis drug market have increased the incidence of TB in Africa and Asia, Emergence of MDR-TB and XDR-TB strains and Increase in an outbreak of TB-HIV co-infection.
The World Health Organization (WHO) the incidence rates in Asia and Africa are high when compared with America and Europe.
The incidence rates are high due to lack of infrastructure, inadequate healthcare facilities, socioeconomic, untapped markets, and behavioral issues in these areas.
Africa has the highest incidence and prevalence rates of TB compared with any other region in the world, with more than three million new TB cases each year.
Market Segmentation
By Therapy Type
First Line Drugs Therapy
Second Line Drugs Therapy
Combination Drugs Therapy
By Type
Latent TB Type
Active Type
View full report: https://www.datamintelligence.com/research-report/tuberculosis-drug-market
Geographical Share
North America
Europe
South America
Asia Pacific
The Middle East and Africa
Key players
Pfizer Inc.
Lupin Laboratories Ltd
AstraZeneca
Novartis AG
Cipla Ltd
Download free sample: https://www.datamintelligence.com/download-sample/tuberculosis-drug-market
About Us
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Contact Information:
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results